NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
about
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channelsCdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease.Inducible ATF3-NFAT axis aggravates podocyte injury.LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis.Huangqi (astragalus) decoction ameliorates diabetic nephropathy via IRS1-PI3K-GLUT signaling pathway
P2860
Q33741426-E3473220-4ED6-4173-AD3F-8D93867A86A3Q36247357-E21854E8-4D88-4550-94F1-2E6EC4CACBD3Q36297539-2F453A9A-C437-4D18-AE2A-D8F91542EF01Q36360722-6D6700AA-2D43-441A-B31D-5CE9B7A35712Q36774995-5F40606D-62D2-47B3-8CCB-0CC6FE2850DBQ37686110-8A3164EC-686F-4389-BE88-D4ADFADE35D8Q38259562-93D5BDB7-8150-49B2-B020-BB05C90CA32AQ38767147-0DDE351D-9CB1-48CC-8848-B0E33D0B5242Q41605771-39523503-335E-4865-8788-31E7703F6591Q47592128-493C8342-88C3-4636-BBD6-18569AC6340CQ50077764-02378DF9-1D5F-4655-8AEB-23C9B3C80E36Q51054784-11D01638-AC27-4D62-8107-6FD150CCBA5CQ53079272-71C55618-130B-4741-A09E-2C7C88D99B8BQ58776038-E01C01A4-8C4B-45F0-8404-1DFEDF13BE15
P2860
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@ast
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@en
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@nl
type
label
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@ast
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@en
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@nl
prefLabel
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@ast
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@en
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@nl
P2093
P2860
P356
P1476
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
@en
P2093
Chunping Yu
Jianchao Ma
Ruizhao Li
Shuangxin Liu
Wenjian Wang
Xiaofan Tan
Xinling Liang
P2860
P304
P356
10.1111/BPH.12292
P407
P577
2013-09-01T00:00:00Z